At one point, we were over 10% down on VEVE. Since mid-April it’s been quietly ticking back up, climbing closer to where we bought in.
There has not been much in the way of policy pivots or glowing headlines to point to.
But this is not unusual — it’s a reminder.
Markets often recover not with fanfare, but with a quiet shrug of resilience. They move ahead of sentiment and discount tomorrow before the headlines have caught up with today.
Headlines rarely capture what really matters in capital markets.
This is why we stay thoughtful, why we diversify and why we focus on process over prediction.
And keep our eyes on long-term outcomes, not short-term reactions.
So while VEVE’s recovery is welcome — it’s not a victory lap.
It’s just another chapter in the story of patient capital, something the headlines never capture, or even try to.